State of Wisconsin Investment Board
DAWN

State of Wisconsin Investment Board’s Day One Biopharmaceuticals DAWN Stock Holding History

State of Wisconsin Investment Board’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$521K Buy
24,299
+873
+4% +$12.3K ﹤0.01% 1983
2025
Q4 		$218K Sell
23,426
-3,566
-13% -$29.8K ﹤0.01% 2251
2025
Q3 		$190K Sell
26,992
-109,284
-80% -$752K ﹤0.01% 2266
2025
Q2 		$886K Buy
136,276
+53,018
+64% +$365K ﹤0.01% 1627
2025
Q1 		$660K Buy
83,258
+24,832
+43% +$268K ﹤0.01% 1639
2024
Q4 		$740K Buy
58,426
+18,740
+47% +$261K ﹤0.01% 1635
2024
Q3 		$553K Buy
39,686
+10,993
+38% +$157K ﹤0.01% 1822
2024
Q2 		$395K Sell
28,693
-1,591
-5% -$23.3K ﹤0.01% 1933
2024
Q1 		$500K Sell
30,284
-24,119
-44% -$361K ﹤0.01% 1758
2023
Q4 		$794K Buy
54,403
+11,593
+27% +$141K ﹤0.01% 1460
2023
Q3 		$525K Sell
42,810
-3,386
-7% -$44.2K ﹤0.01% 1734
2023
Q2 		$552K Buy
+46,196
New +$603K ﹤0.01% 1779

Other funds holding DAWN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return

State of Wisconsin Investment Board's DAWN Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Day One Biopharmaceuticals (DAWN) stake by 3.7% in Q1 2026, buying an estimated $12.3K and bringing the position to 24,299 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #1983.

State of Wisconsin Investment Board first reported a position in DAWN in Q2 2023 and has held it in 12 quarters since. The position peaked at $886K in Q2 2025. 207 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • State of Wisconsin Investment Board held 24,299 shares of Day One Biopharmaceuticals worth $521K as of Q1 2026.
  • State of Wisconsin Investment Board bought 873 Day One Biopharmaceuticals shares in Q1 2026, an estimated $12.3K.
  • Day One Biopharmaceuticals made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1983 holding.
  • State of Wisconsin Investment Board first reported a position in Day One Biopharmaceuticals in Q2 2023 and has held it in 12 quarters since.
  • State of Wisconsin Investment Board's Day One Biopharmaceuticals position peaked at $886K in Q2 2025.
  • 207 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.